4
Changes in Ownership
PULSE BIOSCIENCES, INC. Filed Acc 0001437749-25-029432
Chief Technology Officer sold 45,000 shares at an average $16.25 ($731,200)
- Chief Technology Officer acquired 206,534 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| UECKER DARRIN Chief Technology Officer | 2025-09-16 | Option exercise 10b5-1 | +25,000 | $4.00 | $100,000 | 147,872 | D |
| UECKER DARRIN Chief Technology Officer | 2025-09-16 | Sale 10b5-1 | −25,000 | $16.28 | $407,000 | 122,872 | D |
| UECKER DARRIN Chief Technology Officer | 2025-09-17 | Option exercise 10b5-1 | +20,000 | $4.00 | $80,000 | 142,872 | D |
| UECKER DARRIN Chief Technology Officer | 2025-09-17 | Sale 10b5-1 | −20,000 | $16.21 | $324,200 | 122,872 | D |
| UECKER DARRIN Chief Technology Officer | 2025-09-17 | Option exercise 10b5-1 | +61,534 | $4.00 | $246,136 | 184,406 | D |
| UECKER DARRIN Chief Technology Officer | 2025-09-17 | Option exercise 10b5-1 | +100,000 | $4.00 | $400,000 | 284,406 | D |
| Derivatives | |||||||
| UECKER DARRIN Chief Technology Officer | 2025-09-16 | Option exercise · Stock Option (right to buy) 10b5-1 | −25,000 | 81,534 | D | ||
| UECKER DARRIN Chief Technology Officer | 2025-09-17 | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 61,534 | D | ||
| UECKER DARRIN Chief Technology Officer | 2025-09-17 | Option exercise · Stock Option (right to buy) 10b5-1 | −61,534 | 0 | D | ||
| UECKER DARRIN Chief Technology Officer | 2025-09-17 | Option exercise · Stock Option (right to buy) 10b5-1 | −100,000 | 0 | D | ||
| Open-market sales · 45,000 sh · avg $16.25 · $731,200 | |||||||
Loading xslF345X05/rdgdoc.xml…